Cryoablation of Venous Vascular Malformations

NCT01845935 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-05-14

No results posted yet for this study

Summary

To now, two alternatives for the management of venous vascular malformations are recognized, appropriate to the location, size and patients: sclerosis and surgery. However, sclerosis is effective on symptoms in 80% of cases and excision removes the malformation completely or partially, but it is aggressive and recurrences are common.

Conditions

  • Venous Vascular Malformation

Interventions

DEVICE

Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)

Treatment consists of a percutaneous cryoablation performed under anesthesia and imaging control.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • François Cornelis, MD · University Hospital Bordeaux, France

  • Adelaide Doussau, MD · University Hospital Bordeaux, France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01845935 on ClinicalTrials.gov